Clinical Trials Browser

Influenza, Human × Immune Checkpoint Inhibitors × Thoracic × Clear all

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Carcinoma, Non-Small-Cell Lung, Influenza, Human